| 101922-3 |
Eculizumab Monitoring Panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Eculizumab Monitoring Panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
101922-3 |
|
|
|
|
Order |
|
|
|
0 |
Eculizumab pnl SerPl |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Eculizumab pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101923-1 |
Ravulizumab Monitoring Panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Ravulizumab Monitoring Panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
101923-1 |
|
|
|
|
Order |
|
|
|
0 |
Ravulizumab pnl SerPl |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Ravulizumab pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Ultomiris |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101924-9 |
Transforming growth factor beta 1 |
MCnc |
Urine |
Pt |
Qn |
IA |
|
ACTIVE |
Transforming growth factor beta 1 [Mass/volume] in Urine by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
101924-9 |
|
IA |
|
|
Both |
|
|
|
0 |
TGF-beta-1 Ur IA-mCnc |
|
|
|
N |
|
B; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; i; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; TGF-beta; TGF-beta-1; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 101925-6 |
Epidermal growth factor |
MCnc |
Urine |
Pt |
Qn |
IA |
|
ACTIVE |
Epidermal growth factor [Mass/volume] in Urine by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
101925-6 |
|
IA |
|
|
Both |
|
|
|
0 |
EGF Ur IA-mCnc |
|
|
|
N |
|
Chemistry; EGF; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 101926-4 |
Connective tissue growth factor |
MCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Connective tissue growth factor [Mass/volume] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
101926-4 |
|
IA |
|
|
Both |
|
|
|
0 |
Connective tissue GF Ser IA-mCnc |
|
|
|
N |
|
Chemistry; Conn tiss; Connective tissue GF; CTGF; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.76 |
2.75 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 101927-2 |
Calbindin D28K |
MCnc |
Urine |
Pt |
Qn |
IA |
|
ACTIVE |
Calbindin D28K [Mass/volume] in Urine by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
101927-2 |
|
IA |
|
|
Both |
|
|
|
0 |
Calbindin D28K Ur IA-mCnc |
|
|
|
N |
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; UA; UR; Urn |
2.76 |
2.75 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 101928-0 |
SARS-CoV-2 Ag |
PrThr |
Nasopharynx |
Pt |
Ord |
IF |
|
ACTIVE |
SARS-CoV-2 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101928-0 |
|
IF |
|
|
Both |
|
|
|
0 |
SARS-CoV-2 Ag Nasoph Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Severe Acute Respiratory Syndrome; Time Resolved Fluorescence; TRF |
2.78 |
2.75 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: PROPERTY: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; |
0 |
| 101929-8 |
Supersaturation panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Supersaturation panel - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101929-8 |
|
|
|
|
Order |
|
|
|
0 |
Supersaturation Pnl Ur |
|
|
|
N |
|
Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Supersaturation Pnl; UA; UR; Urn |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 10193-1 |
Physical findings |
Find |
Breasts |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Breasts Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10193-1 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Brsts |
|
|
|
|
|
Brsts; Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101930-6 |
Crystals panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Crystals panel - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101930-6 |
|
|
|
|
Order |
|
|
|
0 |
Crystals Pnl Ur |
|
|
|
N |
|
Chemistry; Crys; Cryst; Crystal; Crystals Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101931-4 |
Calcium oxalate crystals |
EngDiff |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Calcium oxalate crystals [Energy Difference] in Urine |
|
ADD |
DefinitionDescription |
|
|
kJ/mol |
|
|
|
|
|
|
CHEM |
|
101931-4 |
|
|
|
|
Both |
|
|
|
0 |
CaOx cry EngDiff Ur |
|
|
|
N |
|
Ca; CaC2O4; Cal; CaOx; CaOx Cry; Chemistry; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
kJ/mol |
|
|
|
0 |
| 101932-2 |
Calcium hydrogen phosphate dihydrate crystals |
EngDiff |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Calcium hydrogen phosphate dihydrate crystals [Energy Difference] in Urine |
|
ADD |
DefinitionDescription |
|
|
kJ/mol |
|
|
|
|
|
|
CHEM |
|
101932-2 |
|
|
|
|
Both |
|
|
|
0 |
Ca H2 Phos dihyd Cry EngDiff Ur |
|
|
|
N |
|
Brushite; Ca; Ca H2 Phos dihyd; Ca H2 Phos dihyd Cry; Cal; Chemistry; CHPD; Crys; Cryst; Crystal; H2; Hyd; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
kJ/mol |
|
|
|
0 |
| 101933-0 |
Hydroxyapatite crystals |
EngDiff |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyapatite crystals [Energy Difference] in Urine |
|
ADD |
DefinitionDescription |
|
|
kJ/mol |
|
|
|
|
|
|
CHEM |
|
101933-0 |
|
|
|
|
Both |
|
|
|
0 |
EngDiff Ur |
|
|
|
N |
|
Chemistry; Crys; Cryst; Crystal; Hydroxyapatite deposition disease; Hydroxylapatite crystal; Milwaukee shoulder syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Supersaturation; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
kJ/mol |
|
|
|
0 |
| 101934-8 |
Urate Crystals |
EngDiff |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Urate crystals [Energy Difference] in Urine |
|
ADD |
DefinitionDescription |
|
|
kJ/mol |
|
|
|
|
|
|
CHEM |
|
101934-8 |
|
|
|
|
Both |
|
|
|
0 |
Urate Cry EngDiff Ur |
|
|
|
N |
|
Chemistry; Crys; Cryst; Crystal; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urates; Uric acid; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
kJ/mol |
|
|
|
0 |
| 101935-5 |
Sodium Urate Crystals |
EngDiff |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Sodium urate crystals [Energy Difference] in Urine |
|
ADD |
DefinitionDescription |
|
|
kJ/mol |
|
|
|
|
|
|
CHEM |
|
101935-5 |
|
|
|
|
Both |
|
|
|
0 |
Na Urate Cry EngDiff Ur |
|
|
|
N |
|
Chemistry; Crys; Cryst; Crystal; Monosodium Urate; Na; Na Urate; Na Urate Cry; Na+; NaU; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urates; Uric acid; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
kJ/mol |
|
|
|
0 |
| 101936-3 |
Candida albicans DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida albicans DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101936-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C albicans DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Misc; Miscellaneous; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Thrush; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101937-1 |
Candida albicans+glabrata+tropicalis+parapsilosis DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida albicans+glabrata+tropicalis+parapsilosis DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101937-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Can albi+glab+trop+para DNA Spec Ql |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; Cand; Candida alb+ glab+trop+para DNA; Candida albi+glab+trop+para; Candida albi+glab+trop+para DNA; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Misc; Miscellaneous; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Thrush; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101938-9 |
Candida dubliniensis DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida dubliniensis DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101938-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C dubliniensis DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C dubliniensis; C. dubliniensis DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101939-7 |
Candida dubliniensis+lusitaniae+krusei+auris DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida dubliniensis+lusitaniae+krusei+auris DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101939-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C dubl+lusit+krus+auris DNA Spec Ql NAA |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C dubl+lusit+krus+auris; C dubl+lusit+krus+auris DNA; C dubl+lusit+kruse+auris DNA; C dubliniensis; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10194-9 |
Physical findings |
Find |
Neurologic deep tendon reflexes |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Neurologic deep tendon reflexes Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10194-9 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Deep tendon reflexes |
|
|
|
|
|
Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101940-5 |
Candida glabrata DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida glabrata DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101940-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C glabrata DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Torulopsis glabrata; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101941-3 |
Candida glabrata DNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida glabrata DNA [Presence] in Urine by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101941-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C glabrata DNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101942-1 |
Candida lusitaniae DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida lusitaniae DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101942-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C lusitaniae DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C lusitaniae; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101943-9 |
Candida parapsilosis DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida parapsilosis DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101943-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C parap DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101944-7 |
Candida parapsilosis DNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida parapsilosis DNA [Presence] in Urine by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101944-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C parap DNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
